Have problems been experienced in the treatment of eye patients during the COVID-19 pandemic?

To investigate whether there are delays in the treatment of patients with eye diseases during the Covid-19 pandemic. Two hundred patients were included in the study. The problems experienced in the treatment of the patients due to the pandemic and the cause of these problems were investigated. The number of patients whose treatment was delayed was 84 and the mean delay time in treatment was 4.51±2.16 months. The patients who delayed the treatment the most were patients with glaucoma, retinal vascular occlusion, cataract, diabetes mellitus, age-related macular degeneration, and hypertension (86%, 75%, 64%, 53%, 43%, 33%, respectively). The rate of patients presenting due to decreased visual acuity was 24%. It was observed that 39% of all patients had coronaphobia. It is obvious that pandemic disrupts the treatment process of many diseases, including eye diseases. It will be beneficial to create new treatments and follow-up protocols for chronic eye diseases for pandemic periods.

PDF

___

WHO. WHO's COVID-19 data. https://covid19.who.int access date 15.02.2021
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603-2615.
Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403-16.
Temgoua MN, Endomba FT, Nkeck JR, et al. Coronavirus disease 2019 (COVID-19) as a multi-systemic disease and its impact in low-and middleincome countries (LMICs). SN Compr Clin Med. 2020;2:1377–87.
Mi J, Zhong W, Huang C, et al. Gender, age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia. Am J Transl Res. 2020;12(10):6537.
Yoldas MA, Yoldas H. Pediatric COVID-19 Disease: A Review of the Recent Literature. Pediatric Annals. 2020;49:e319-e325.
Kumar D, Dey T. Treatment delays in oncology patients during COVID-19 pandemic: A perspective. J Glob Health. 2020;10:010367.
Nair AG, Gandhi RA, Natarajan S. Effect of COVID-19 related lockdown on ophthalmic practice and patient care in India: Results of a survey. Indian J Ophthalmol. 2020;68(5):725-730.
Cohen S, Sprung C, Sjokvist P, et al. Communication of end-of-life decisions in European intensive care units. Intensive Care Med. 2005;31:15-21.
Mahmud E, Dauerman HL, Welt FG, et al. Management of acute myocardial infarction during the COVID-19 pandemic. JACC. 2020;76:1375-84.
Bhaskar S, Bradley S, Chattu VK, et al. Telemedicine across the globeposition paper from the COVID-19 pandemic health system resilience PROGRAM (REPROGRAM) international consortium (Part 1). Front Public Health. 2020;8:556720.
Fagherazzi G, Goetzinger C, Rashid MA, et al. Digital health strategies to fight COVID-19 worldwide: challenges, recommendations, and a call for papers. J Med Internet Res. 2020;22:e19284.
Saleem SM, Pasquale LR, Sidoti PA, et al. Virtual ophthalmology: telemedicine in a Covid-19 era. Am J Ophthalmol. 2020;216:237-242.
Parrish RK, II EJH. What Does Telemedicine Mean for the Care of Patients With Glaucoma in the Age of COVID-19?. Am J Ophthalmol. 2020;218:A1–A2.
Korobelnik J-F, Loewenstein A, Eldem B, et al. Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. Graefes Arch Clin Exp Ophthalmol. 2020;258:1149.
Saleh OA, Jammal H, Alqudah N, et al. Clinical experience in the administration of intravitreal injection therapy at a tertiary university hospital in Jordan during the COVID-19 lockdown. Clin Ophthalmol. 2020;14:2473.
Jayaram H, Strouthidis NG, Gazzard G. The COVID-19 pandemic will redefine the future delivery of glaucoma care. Eye. 2020;34:1203–5.
Wan KH, Huang SS, Young AL, et al. Precautionary measures needed for ophthalmologists during pandemic of the coronavirus disease 2019 (COVID‐19). Acta Ophthalmol. 2020;98:221-22.
Asmundson GJ, Taylor S. Coronaphobia: Fear and the 2019-nCoV outbreak. J Anxiety Disord. 2020;70:102196.
Arora A, Jha AK, Alat P, et al. Understanding coronaphobia. Asian Journal of Psychiatry. 2020;54:102384.
Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-79.
Song W, Singh RP, Rachitskaya AV. The Effect of Delay in Care Among Patients Requiring Intravitreal Injections. Ophthalmology Retina. 2020.
Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI insight. 2017;2.
Meyer-Rüsenberg B, Pavlidis M, Stupp T, et al. Pathological changes in human retinal ganglion cells associated with diabetic and hypertensive retinopathy. Graefes Arch Clin Exp Ophthalmol. 2006;245:1009-18.
Cotter S. Pediatric Eye Disease Investigator Group 2006 Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology.113:895-903.
Rutar T, Porco TC, Naseri A. Risk factors for intraoperative complications in resident-performed phacoemulsification surgery. Ophthalmology. 2009;116:431-6.
Eijk ES, Busschbach JJ, Timman R, et al. What made you wait so long? Delays in presentation of retinal detachment: knowledge is related to an attached macula. Acta Ophthalmol. 2016;94:434-40